Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Is Exilis worth the money
Increased Interleukin-23 is Associated With Increased Disease Activity in Patients With Rheumatoid Arthritis
Priority Applications (1) Applications Claiming Priority (1) Publications (2) Family ID=44842263 Family Applications (1) Country Status (1) Cited By (6) Citations (6) 2011 2011-05-05 CN CN201110114806XA patent/CN102229649B/en active Active
At 21 days of age female SpragueDawley rats (Charles River Laboratories International) were injected with 50 mg MNU/kg body weight, i.p
First, it seemed to calm inflammation
This outperformance of an established clinical therapy suggests significant potential for diabetic wound applications
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
